Weighted collagen microsponge for immobilizing bioactive material

• US 4,997,753 A
• Filed: 08/14/1989
• Issued: 03/05/1991
• Est. Priority Date: 04/04/1985
• Status: Expired due to Fees

• Current Assignee: Cellex Life Sciences, Inc.
• Original Assignee: Verax Corporation
• Inventors: Silver, Frederick H., Runstadler, Peter W. Jr., Berg, Richard A., Dean, Robert C. Jr., Phillips, Philip G.
• Primary Examiner(s): Naff, David M.
• Application Number:
  US07/393,656
• Time in Patent Office: 568 Days
• Field of Search: 435/68, 435/174, 435/176, 435/177, 435/240.23, 435/240.24, 435/240.26, 435/252.3, 435/170, 435/171, 435/172.1, 530/356, 436/548
• US Class Current: 435/69.1
• CPC Class Codes: C12N 1/00 Microorganisms, e.g. protozoa; Compositions thereof medicinal preparations containing material from protozoa, bacteria or viruses A61K35/66, from algae A61K36/02, from fungi A61K36/06; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K39/00; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
• CPC Class Codes: C12N 11/02 Enzymes or microbial cells immobilised on or in an organic carrier
• CPC Class Codes: C12N 2533/54 Collagen; Gelatin
• CPC Class Codes: C12N 5/0075 using microcarriers
• CPC Class Codes: C12P 1/00 Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes

Abstract

Weighted collagen microsponges having a highly crosslinked collagen matrix are described suitable for use in culturing organisms in motive reactor systems. The microsponges have an open to the surface pore structure, and pore sizes and volumes suitable for immobilizing a variety of bioactive materials. The microsponges also have an average particle size in the range of about 100 to about 1000 microns and a specific gravity above about 1.05.

Claims

1. A weighted collagen microsponge for immobilizing bioactive materials in motive bioreactor systems, said microsponge comprising a porous, biocompatible, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 micron to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05.

2. The microsponge of claim 1 having immobilized therein bioactive material selected from the group consisting of enzymes, dead cells and living cells.

3. The microsponge of claim 1 wherein said inert weighting material is selected from the group consisting of metals, metal alloys, metal oxides and ceramics.

4. The microsponge of claim 3 wherein said weighting material has a specific gravity of above about 4.0 and said microsponge has a specific gravity of above about 1.3.

5. The microsponge of claim 4 wherein said inert weighting material is dispersed throughout said collagen matrix as finely divided powder.

6. The microsponge of claim 4 wherein said weighting material is centrally disposed as a solid core about which said collagen matrix is formed.

7. The microsponge of claim 4 wherein said inert weighting material is selected from the group consisting of chromium, tungsten, cobalt, molybdenum, titanium, nickel and alloys thereof.

8. The microsponge of claim 7 wherein said weighting material is titanium and said microsponge has hybridoma cells immobilized therein.

9. The microsponge of claim 2, wherein the cells are microorganisms.

10. A bioreactor system comprising a reactor vessel having aseptically sealed therein a plurality of sterilized weighted collagen microsponges for immobilizing bioactive materials in motive bioreactor systems, said microsponges comprising a porous, biocompatible, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity of above about 1.05.

11. The biorector system of claim 10 wherein said reactor has a volume between about 0.1 to 10 liters.

12. The bioreactor system of claim 11 wherein said reactor is a fluidized bed reactor, having a fluid distribution plate.

13. A process for performing a bioreaction comprising immobilizing a bioactive material in weighted collagen microsponges comprising a porous, biocompatible, biostable, insoluble highly crosslinked collagen matrix containing an inert weighting material, said collagen matrix having an open to the surface pore structure with an average pore size in the range of from about 1 micron to about 150 microns, the pores of said matrix occupying from about 70 to about 98% by volume of the microsponge, said microsponge also having an average particle size of from about 100 to about 1000 microns and a specific gravity above about 1.05;

retaining the microsponges having said immobilized bioactive material in a suitable reactor vessel;

passing a liquid reagent stream into said reactor in direct contact with said microsponges;

agitating the mixture of said microsponges and said reagent stream and recovering the biochemical reaction products from said reactor.

14. The process of claim 13 wherein said bioactive material is organisms, the microsponges are incubated to promote growth and colonization of said microsponges by said organisms, said reagent comprises nutrient media for promoting the growth and metabolism of said organisms, and wherein said product comprises metabolites of said organisms.

15. The process of claim 13 wherein said bioactive material is organisms and the recovered product comprises free organisms which have escaped from said microsponges.

16. The process of claim 14 wherein said organisms comprise hybridomas and said product comprises monoclonal antibodies.

17. The process of claim 16 wherein said reactor vessel comprises a fluidized bed reactor.

18. The process of claim 14 wherein said organisms comprise mammalian cells and said products comprise mammalian cell products.

19. The process of claim 14 wherein said organisms are genetically engineered microbial cells and said product comprises secreted protein products.

20. The process of claim 15 wherein said organisms are genetically engineered microbial cells and said product comprises said organisms containing a non-secreted protein product.